Replies to post #63904 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Of course the equivalence and single dose will have a larger initial impact. But, during negotiations for a license or partner the non-resistance will play a big role in valuation.

Given those perimeters: upfront >$50 million; total benchmarks >$400 million; royalties >17%